Elevance Health Inc. ($ELV) Stock Forecast: Up 1.3% Today

What is Elevance Health Inc.?

Asset Elevance Health, Inc. (NYSE: ELV) is a company in the healthcare sector, offering digital care delivery and clinical services. The stock exhibited a notable upward trend today.

Why is Elevance Health Inc. going up?

ELV stock is up 1.3% on Jan 5, 2026 16:00

• ELV stock saw a positive movement today, possibly influenced by favorable updates regarding its collaboration with American Well.
• The extension of the partnership with American Well under new three-year agreements represents a significant benefit for ELV, signaling continued growth potential in digital healthcare.
• The robust Q3 earnings results, surpassing expectations with strong EPS and revenue numbers, also played a role in the positive market sentiment towards Elevance Health.
• In summary, the mix of enhanced partnership agreements and impressive financial performance likely boosted investor confidence in ELV, resulting in the upward movement in the market.

ELV Price Chart

ELV Technical Analysis

ELV News

Barclays upgrades Centene stock rating to Overweight on ACA margin upside

Barclays has upgraded Centene (NYSE:CNC) from Equalweight to Overweight and raised its price target to $54.00, citing potential margin improvements in the company's Affordable Care Act (ACA) exchange business. The upgrade is based on Centene's strong premium increases and stable competitive positioning expected to lead to 2.0% ACA margins by 2026, exceeding Street estimates for EPS in 2026 and 2027. Despite past challenges, Centene's financial health is rated "GREAT" by InvestingPro.

https://www.investing.com/news/analyst-ratings/barclays-upgrades-centene-stock-rating-to-overweight-on-aca-margin-upside-93CH-4429197

Elevance Health, Inc. (NYSE:ELV) Given Average Rating of "Hold" by Brokerages

Elevance Health, Inc. (NYSE:ELV) has received an average "Hold" rating from twenty-four brokerages, with an average one-year price target of $396.21. The company recently reported strong Q3 earnings, beating consensus estimates with $6.03 EPS and $50.09 billion in revenue. Institutional investors hold a significant portion of shares, and the company pays a quarterly dividend of $1.71.

https://www.marketbeat.com/instant-alerts/elevance-health-inc-nyseelv-given-average-rating-of-hold-by-brokerages-2026-01-04/

American Well extends Elevance Health partnership with new three-year agreements

American Well (NYSE:AMWL) has renewed its partnership with Elevance Health, Inc. through new three-year agreements, effective January 1, 2026. This extension allows AMWL to continue operating Elevance Health's LiveHealth Online brand, providing digital care delivery and clinical services. Despite a recent revenue decrease in Q3 2025, AMWL is focusing on AI-driven healthcare solutions for long-term growth.

https://www.investing.com/news/sec-filings/american-well-extends-elevance-health-partnership-with-new-threeyear-agreements-93CH-4428397

American Well extends Elevance Health partnership with new three-year agreements By Investing.com

American Well Corporation (NYSE:AMWL) has renewed its partnership with Elevance Health, Inc. through new agreements effective January 1, 2026. These three-year agreements extend the existing collaboration for AMWL to operate a white-labeled digital care delivery platform, LiveHealth Online, and involve American Well's clinical partner, Online Care Group, PC, continuing to provide clinical services. This strategic extension is significant for AMWL, which also reported a recent 7.91% stock return despite a Q3 2025 revenue decrease.

https://za.investing.com/news/sec-filings/american-well-extends-elevance-health-partnership-with-new-threeyear-agreements-93CH-4045561

American Well (NYSE: AMWL) renews Elevance Health LiveHealth Online deal

American Well (NYSE: AMWL) has renewed its multi-year partnership with Elevance Health, Inc. for digital care services, including the continued operation of the LiveHealth Online platform. The agreements, effective January 1, 2026, extend for three years with automatic one-year renewals and obligate Elevance Health to pay annual subscription fees. American Well's clinical partner, Online Care Group, PC, also renewed related provider agreements for the same term, ensuring continued access to a 50-state network of clinicians for Elevance Health members.

https://www.stocktitan.net/sec-filings/AMWL/8-k-american-well-corp-reports-material-event-8a7adc68dab5.html

Trending Today

Silver ($XAG) Commodity Forecast: Down 5.4% Today

Aave ($AAVE) Crypto Forecast: Down 5.3% Today

Astera Labs Inc ($ALAB) Stock Forecast: Up 6.9% Today

Blink Charging Co. ($BLNK) Stock Forecast: Down 5.1% Today

Teladoc Health Inc. ($TDOC) Stock Forecast: Down 5.0% Today

First Solar Inc. ($FSLR) Stock Forecast: Down 11.0% Today

Sysco Corporation ($SYY) Stock Forecast: Down 1.2% Today

FuelCell Energy ($FCEL) Stock Forecast: Down 7.6% Today

Circle Internet Group ($CRCL) Stock Forecast: Down 5.4% Today

Western Digital Corporation ($WDC) Stock Forecast: Down 8.6% Today

Elevance Health Inc. Price History

22.09.2025 - ELV Stock was down 0.8%

• Despite surpassing earnings estimates, ELV faced a downward trend attributable to Medicare cost pressures, Obamacare plan dynamics, and Medicaid attrition, influencing investor sentiment.
• The Q3 performance, marked by significant Medicare Advantage membership growth and Carelon revenue increase, was overshadowed by Medicaid losses impacting the stock's value.
• Analysts' projections concerning ELV's Q3 earnings did not fully anticipate the challenges stemming from Medicare cost pressures and Medicaid attrition, contributing to the recent bearish market trend.

15.07.2025 - ELV Stock was up 5.0%

• Despite a recent decline in YTD performance, ELV showed a strong bullish movement today, indicating a potential turnaround in investor sentiment.
• The company's cost-cutting measures and focus on commercial growth may have positively impacted the stock price.
• Analyst pessimism and concerns over rising costs could have been overshadowed by the company's efforts to address these issues, leading to the bullish market movement.
• ELV's strategic initiatives to stabilize performance and leverage long-term growth levers seem to have resonated well with investors, driving the stock higher.

05.00.2026 - ELV Stock was up 1.3%

• ELV stock saw a positive movement today, possibly influenced by favorable updates regarding its collaboration with American Well.
• The extension of the partnership with American Well under new three-year agreements represents a significant benefit for ELV, signaling continued growth potential in digital healthcare.
• The robust Q3 earnings results, surpassing expectations with strong EPS and revenue numbers, also played a role in the positive market sentiment towards Elevance Health.
• In summary, the mix of enhanced partnership agreements and impressive financial performance likely boosted investor confidence in ELV, resulting in the upward movement in the market.

31.09.2025 - ELV Stock was down 5.1%

• The surge in implied volatility for Elevance Health stock options indicates increased uncertainty and potential downside risk perceived by investors.
• The heightened options activity could suggest speculation or hedging strategies being implemented by market participants, reflecting a lack of confidence in ELV's short-term outlook.
• The overall bearish movement in ELV's stock price today might be attributed to the escalating concerns and cautious sentiment among investors, as reflected in the options market activity.

18.06.2025 - ELV Stock was down 6.1%

• ELV stock experienced a strong bearish movement today due to a series of negative news and analyst actions.
• The company's Q2 earnings missed estimates, with EPS sliding and facing pressure from rising medical costs, particularly from Medicaid and ACA expenses.
• Despite a 14.3% Y/Y increase in Q2 revenue, ELV's FY25 EPS guidance was cut below consensus, citing higher costs.
• Analyst downgrades and concerns about rising costs and lower Medicaid memberships contributed to the bearish market movement of ELV today.

18.06.2025 - ELV Stock was down 8.4%

• ELV's Q2 earnings fell short of expectations because of escalating medical expenses, mainly from Medicaid and ACA costs.
• Although there was a 14.3% rise in Q2 revenue compared to the previous year, the company reduced its projected FY25 EPS, pointing to increased ACA and Medicaid expenses as the main factors.
• Analysts issued downgrades on Elevance Health, which added to the pessimistic outlook on the stock.
• Concerns about surging costs and declining Medicaid enrollments affecting ELV's profitability in the second quarter led to a negative market response.

03.09.2025 - ELV Stock was up 5.2%

• ELV's bullish movement could be attributed to Cigna expanding coverage to Cleerly's AI cardiovascular imaging solutions.
• The partnership with Cigna is seen as a significant endorsement of ELV's technology, leading to increased investor confidence and driving the stock price higher.
• This development highlights the growing importance of early detection and digital healthcare solutions, positioning ELV as a key player in the evolving healthcare industry.

11.11.2025 - ELV Stock was up 6.0%

• Elevance Health (ELV) has shown a strong bullish movement in the market recently.
• The appointment of Amy W. Schulman as an independent director is being viewed positively, enhancing the company's governance and oversight capabilities.
• Analysts have adjusted the price target for ELV to $340 from $297, maintaining a Neutral rating, indicating increased confidence in the stock's potential.
• Prominent investors like David Tepper and Michael Burry have been actively investing in ELV, signaling trust in its undervaluation and future growth.
• Despite facing challenges like rising Medical Care Ratios and regulatory changes, Elevance Health's strategic actions, such as reducing its Medicare Advantage membership and utilizing its balance sheet, are setting the stage for margin recovery and expansion.

11.11.2025 - ELV Stock was up 6.9%

• Adjusting the price target to $340 from $297 and maintaining a Neutral rating could have instilled confidence in investors, leading to increased buying activity.
• The appointment of Amy W. Schulman as an independent director, known for her expertise in healthcare innovation and governance, may have signaled to the market a strategic move towards strengthening governance and oversight capabilities, positively impacting investor sentiment.
• The reaffirmation of 2025 earnings guidance at $24.70 per share in a recent SEC filing could have provided clarity and reassurance to investors, further supporting the bullish momentum in the stock.
• The focus on board refreshment strategy with diverse and independent leadership aligns with market trends towards corporate governance best practices, potentially attracting more investors to the stock.

11.11.2025 - ELV Stock was up 5.5%

• ELV experienced a strong bullish movement today.
• The appointment of Amy W. Schulman, a distinguished healthcare executive, to the company's board of directors seems to have boosted investor confidence in ELV's governance and strategic direction.
• Analysts' positive outlook on ELV, with a 'Buy' rating and a median price target of $394, further contributed to the bullish sentiment.
• ELV's focus on healthcare innovation and strategic growth initiatives align well with market trends emphasizing technology-driven approaches in the healthcare sector.

21.09.2025 - ELV Stock was up 0.0%

• ELV's bullish movement could be attributed to positive projections for key metrics ahead of its Q3 earnings report.
• Investors may be optimistic about the company's performance in the quarter ended September 2025, leading to increased buying activity.
• The anticipation of strong financial results and key metrics could be driving the bullish sentiment in ELV's stock today.

02.00.2026 - ELV Stock was up 1.0%

• ELV's stock showed a strong bullish movement recently.
• Significant new investment in ELV was made during the third quarter, reflecting confidence in the company's future prospects.
• ELV reported impressive Q3 earnings, surpassing expectations.
• Investors are keeping a close eye on ELV's performance and upcoming earnings release to assess the impact of their capital allocation strategies on shareholder returns.